| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/13/2004 | US6676985 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 01/13/2004 | US6676949 Two-step immunization procedure against Chlamydia infection |
| 01/13/2004 | US6676945 Induction immunology response |
| 01/13/2004 | US6676944 Vaccine containing a peroxiredoxin and/or a β-tubulin |
| 01/13/2004 | US6676943 Human complement C3-degrading protein from Streptococcus pneumoniae |
| 01/08/2004 | WO2004003513A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | WO2004003511A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | WO2004003235A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | WO2004003231A2 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 01/08/2004 | WO2004003209A2 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | WO2004003206A1 Novel transglucuronidases and genes tehreof |
| 01/08/2004 | WO2004003202A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 01/08/2004 | WO2004003197A1 Yeast-origin promoter and vector and expression system using the same |
| 01/08/2004 | WO2004003187A2 Mpg added to fermentation |
| 01/08/2004 | WO2004003186A2 Subtilases and subtilase variants having altered immunogenicity |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003175A2 Process and materials for production of glucosamine and n-acetylglucosamine |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003139A2 Modified shine-dalgarno sequences and methods of use thereof |
| 01/08/2004 | WO2004003135A2 Selective cloning of homoduplex nucleic acids |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 01/08/2004 | WO2004002223A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | WO2003089625A3 Product |
| 01/08/2004 | WO2003063766A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 01/08/2004 | WO2003031570A3 METHOD FOR CLONING AND EXPRESSION OF BseRI RESTRICTION ENDONUCLEASE AND BseRI METHYLASE IN E. COLI |
| 01/08/2004 | WO2003025169A3 Nucleic acid for cloning vector |
| 01/08/2004 | WO2003020897A3 Compositions and methods relating to ovary specific genes and proteins |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003008610A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pfkb gene |
| 01/08/2004 | WO2003008609A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pykf gene |
| 01/08/2004 | WO2003007800A3 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002092765A3 Novel telomerase inhibitors and uses therefor |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002066654A3 Drug metabolizing enzymes |
| 01/08/2004 | WO2002066622A3 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002046458A3 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 01/08/2004 | WO2002046354A3 Automated imaging and harvesting of colonies of thin film culture devices |
| 01/08/2004 | WO2000052135A3 Engineering intracellular sialylation pathways |
| 01/08/2004 | US20040006789 Pseudomonas syringae harpins, HopPtoP and HopPmaHpto, and their uses |
| 01/08/2004 | US20040006785 For controlling flea beetles of the genus Phyllotreta |
| 01/08/2004 | US20040006780 VEGF-modulated genes and methods employing them |
| 01/08/2004 | US20040006217 Comprises coagulation factor VIIa/VII receptor for treatment and prevention of thrombosis, septic shock and adult respiratory distress syndrome (ARDS); anticoagulants; thrombolytic agents |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006205 Comprises g-protein coupled receptor polypeptides for diagnosis, prevention and treatment of cancers, infections and dyslipidemias |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040005700 Poroplasts |
| 01/08/2004 | US20040005695 Culturing genetically engineered escherichia and/or klebsiella coding phytase and/or amylase and recovering enzymatic polypeptides |
| 01/08/2004 | US20040005692 Comprises nucleotide sequences coding amidase (AMDS) for use as diagnostic tool in genetic engineering |
| 01/08/2004 | US20040005691 Comprises genetically engineered beta-site amyloid precursor protein-cleaving enzyme (BACE) for prevention, diagnosis and treatment of neurodegenerative and alzheimer's diseases |
| 01/08/2004 | US20040005690 Modified CBD/RGD recombinant attachment factor for improving cell-attachment efficiency and the manufacturing method thereof |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005680 Activated yeast cell culture for improving immune functions of animals; health foods, drinks and supplement; immunosuppression; immunotherapy |
| 01/08/2004 | US20040005678 Introducing into host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate |
| 01/08/2004 | US20040005677 Producing and extracting optically pure lactic acid for use in food processing, brewing, tanning and liquid crystals |
| 01/08/2004 | US20040005675 Nucleotide sequences encoding the ptsH gene |
| 01/08/2004 | US20040005667 Comprises protein for developing vaccines which prevent chlamydial infections; genetic vaccines |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005662 Culuring transgenic cells which codes bactericides; genetic vaccines |
| 01/08/2004 | US20040005655 Comprises nucleotides equences coding enzymatic polypeptides for destroying or detecting hydrogen peroxide and producing glyoxylic acid; bleaching; bactericide; papermaking |
| 01/08/2004 | US20040005652 Nutrient base to facilitate growth of Bacillus cereus, Bacillus thuringiensis and Bacillus anthrasis, chromogenic substrate that changes color responsive to presence of PC-PLC enzymes, ingredient that promotes expression of enzymes |
| 01/08/2004 | US20040005648 PYK2 related products and methods |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005639 Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005600 Designing expression vector for improved accumulation of plasmodium protein in transformed cells |
| 01/08/2004 | US20040005599 Heat resistant polymerase with improved accuracy in replication and amplification |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005589 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 01/08/2004 | US20040005587 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005578 Myocardial cell proliferation-associated genes |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005539 Comprises expression vector coding antibody domains and heterologous proteins for use as model in design of improved binding domains; enzyme inhibitors |
| 01/08/2004 | US20040005348 Isolated and purified strain of the species Lactobacillus sanfranciscensis which produces levan. The present invention further relates to a method of producing the levan, and to a method of preparing various human or pet food products or |
| 01/08/2004 | US20040005337 Dietary supplements for improving kidney function |
| 01/08/2004 | US20040005336 Plurality of yeast cells, wherein said plurality of yeast cells have been cultured in the presence of an alternating electric field having a specific frequency and a specific field strength for a period of time sufficient to increase the |
| 01/08/2004 | US20040005335 Oral compositions for HIV-infected subjects |
| 01/08/2004 | US20040005332 Application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005325 Helicobacter felis vaccine |
| 01/08/2004 | US20040005324 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 01/08/2004 | US20040005305 Nutritional composition for treating an immune condition |
| 01/08/2004 | CA2491480A1 Humanized anti-lymphotoxin beta receptor antibodies |
| 01/08/2004 | CA2491392A1 Compositions and methods for determining the replication capacity of a pathogenic virus |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | CA2490256A1 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | CA2490017A1 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | CA2490016A1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 01/08/2004 | CA2488853A1 Process and materials for production of glucosamine and n-acetylglucosamine |